Ketorolac Dose in Postoperative Pain
For adults with postoperative pain, administer ketorolac 30 mg IV every 6 hours (maximum 120 mg/day) for patients under 65 years, or 15 mg IV every 6 hours (maximum 60 mg/day) for patients ≥65 years, renally impaired, or <50 kg, with treatment duration not exceeding 5 days. 1
Dosing Algorithm
Single-Dose Regimen (Initial Treatment)
Intravenous administration (preferred for rapid onset):
- Age <65 years: 30 mg IV over ≥15 seconds 1
- Age ≥65 years, renal impairment, or weight <50 kg: 15 mg IV over ≥15 seconds 1
Intramuscular administration (alternative):
- Age <65 years: 60 mg IM (deep, slow injection) 1
- Age ≥65 years, renal impairment, or weight <50 kg: 30 mg IM 1
Multiple-Dose Regimen (Continued Treatment)
Standard adult dosing:
- Age <65 years: 30 mg IV/IM every 6 hours (maximum 120 mg/day) 1
- Age ≥65 years, renal impairment, or weight <50 kg: 15 mg IV/IM every 6 hours (maximum 60 mg/day) 1
Critical duration limit: Maximum 5 days total therapy (IV + oral combined) 1
Evidence Supporting This Dosing
The FDA-approved dosing is supported by clinical trial data showing that ketorolac 30 mg initial dose followed by 15 mg every 3 hours reduced morphine requirements by 26% compared to placebo in postoperative patients using PCA morphine 1. A meta-analysis demonstrated that the 60 mg dose (equivalent to the higher single IM dose) provides significant opioid-sparing effects with mean reduction of 1.64 mg IV morphine equivalents, while evidence for 30 mg benefits is less robust 2.
Important finding: A non-inferiority trial comparing 15 mg vs 30 mg ketorolac after spine surgery failed to demonstrate non-inferiority of the lower dose, suggesting 30 mg is superior for adequate analgesia 3. This supports using the full 30 mg dose in standard adult patients rather than routinely reducing to 15 mg.
Multimodal Integration
Ketorolac should be incorporated into a multimodal analgesic regimen rather than used as monotherapy 4. The most effective combinations include:
- Acetaminophen: 1 gram IV every 6-8 hours (around-the-clock dosing) 4
- Regional anesthesia: When feasible for the surgical site 4
- Opioids: For breakthrough pain only, not scheduled 1
The 2021 PROSPECT guidelines for prostatectomy consistently show ketorolac used alongside paracetamol with opioids reserved for rescue 5. This approach maximizes analgesia while minimizing opioid-related adverse effects.
Critical Safety Considerations
Absolute Contraindications
- Renal dysfunction: Creatinine clearance <50 mL/min 6
- Active peptic ulcer disease or GI bleeding 6
- Cardiovascular disease or atherothrombosis (stroke, MI, PAD) 7
- Concurrent therapeutic anticoagulation (warfarin, heparin, rivaroxaban) 7
High-Risk Populations Requiring Dose Reduction (15 mg)
- Age ≥65 years 1
- Weight <50 kg 1
- Any degree of renal impairment 1
- Preexisting renal dysfunction, aspirin use, or single-ventricle palliation (pediatric cardiac surgery context) 8
Monitoring Requirements
Baseline and every 3 months (if approaching maximum duration):
- Blood pressure
- BUN and creatinine
- Liver function tests (alkaline phosphatase, LDH, AST, ALT)
- CBC and fecal occult blood 6
Discontinue immediately if:
- BUN or creatinine doubles 6
- Liver enzymes >3× upper limit of normal 6
- Hypertension develops or worsens 6
- Peptic ulcer or GI hemorrhage occurs 6
Timing and Administration
Onset of action: 30 minutes, with maximum effect at 1-2 hours 1
Duration of analgesia: 4-6 hours 1
Administration technique:
- IV bolus must be given over ≥15 seconds (never rapid push) 1
- IM injection should be deep and slow into muscle 1
Incompatibilities: Do not mix in syringe with morphine sulfate, meperidine, promethazine, or hydroxyzine (causes precipitation) 1
Pediatric Dosing Context
While the question asks about adults, the pediatric guidelines provide useful context. In children, ketorolac dosing is:
- Intraoperative single dose: 0.5-1 mg/kg up to 30 mg 9
- Postoperative maintenance: 0.15-0.2 mg/kg (max 10 mg) every 6 hours for maximum 48 hours 9
This demonstrates the principle of weight-based dosing with absolute maximum caps, which informs the adult dosing for patients <50 kg.
Common Pitfalls to Avoid
Exceeding 5-day duration: This is the single most important safety limit. The risk of serious adverse events increases substantially beyond 5 days 1
Using in cardiovascular surgery without careful consideration: Limited safety data exists in this population 10
Combining with therapeutic anticoagulation: This multiplies bleeding risk by 2.5-fold 7
Failing to correct hypovolemia first: Always ensure adequate fluid status before administering ketorolac 1
Not switching to alternative analgesics: Ketorolac is for short-term acute pain only; transition to other agents as soon as clinically appropriate 1
Increasing dose or frequency for breakthrough pain: Instead, supplement with low-dose opioids PRN 1